RankingsPricing
  1. JP-listed companies
  2. OncoTherapy Science, Inc.
  3. Financials
  4. Revenue

OncoTherapy Science, Inc.【JP:4564】

Market cap
¥6.7B
P/E ratio
SummaryFinancialsDividendsHistoryOwnershipWorkforce
Period EndRevenue (Million JPY)YoY (%)
Mar 31, 2025750+22.93%
Mar 31, 2024610-46.24%
Mar 31, 20231,135-1.63%
Mar 31, 20221,154+246.99%
Mar 31, 2021332+5.14%
Mar 31, 2020316+12.70%
Mar 31, 2019281+32.82%
Mar 31, 2018211-26.31%
Mar 31, 2017287+7.40%
Mar 31, 2016267-65.34%
Mar 31, 2015770-24.35%
Mar 31, 20141,018-68.95%
Mar 31, 20133,277-47.34%
Mar 31, 20126,224

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating income Operating expenses Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSAdjusted EPSDividend payout ratio (%)Dividend per shareAdjusted DPSEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)